Myology research highlights
RSS feedRisdiplam in SMA: feedback from adults in France
Practitioners at the Neuromuscular Reference Centre at the Henri-Mondor University Hospital (Créteil) report their real-life experience of treating six adults with SMA: four with type II SMA and two with type III SMA participated in this observational study, two had initially received intrathecal nusinersen and were then switched to risdiplam, the observation period varied between … [Read more]
French experience with Zolgensma® in type I SMA
Between June 2019 and June 2022, 95 children with treatment-naive type I SMA were identified in one of the 23 neuromuscular disease centres of reference. A study of ‘real-life’ data was carried out by a committee of French experts on 29 of these children, who were treated exclusively with Zolgensma®, with follow-up of at least … [Read more]
Use of psychostimulants to treat daytime hypersomnolence in myotonic dystrophies
A Cochrane review of clinical trials evaluating psychostimulant drugs in myotonic dystrophies was published in November 2024. Six clinical trials were selected, involving 136 participants. According to patient feedback, these drugs may reduce daytime sleepiness, but do not improve quality of life. There were discrepancies between the various trials, making the conclusions uncertain. In addition, … [Read more]
A natural history of FSHD established after five years of observation
Dutch researchers have designed a follow-up protocol for patients suffering from facioscapulohumeral muscular dystrophy (FSHD) in order to gain a better understanding of the natural history of this disease: 154 symptomatic patients confirmed by molecular biology were included in the study, the median age of the cohort was 51 years, a battery of tests and … [Read more]
DMD: a summary of the factors correlated with cardiac damage
A review of the literature on predictors of cardiac involvement in Duchenne muscular dystrophy included 33 articles concerning 9,232 patients. Most (76%) were retrospective studies, 15% randomised studies, 6% prospective cohort studies and 3% case series. Cardiac treatments were significantly associated with preserved systolic ejection fraction, with a moderate to high level of evidence. Mutations … [Read more]
NDUFA11, a possible autoantigen in inclusion body myositis
An international study involving the Nice University Hospital and the Pitié-Salpêtrière Hospital : evaluated IgG reactivity to a panel of 357 proteins in a total of 874 people, including 31 with sporadic inclusion myositis; IgG anti-NDUFA11 (for NADH dehydrogenase 1 α subcomplex 11) was found to be more frequent in inclusion myositis (9.7% of cases) … [Read more]
New European recommendations for Pompe disease
The European Reference Network for Metabolic Diseases (MetabERN) has drawn up new recommendations for Pompe disease, the most common muscular glycogenosis: experts in the field and members of MetabERN have analysed the recent literature on the subject, focusing on the results of various therapeutic trials, a rigorous methodology was used to create a standardised database … [Read more]
Towards a better understanding of myopathy linked to the DNAJB4 gene
An international consortium of researchers and clinicians report the clinical and biological data of patients diagnosed with DNAJB4-related myopathy: 5 families of distinct and unrelated ethnic origins were included in the study following the discovery of 5 pathogenic variants of the DNAJB4 gene, including three with loss of function, the clinical picture combined spinal rigidity … [Read more]
For once, a heterozygous variant of the TTN gene can lead to a dominant myopathy
The 14 members (eight affected and six healthy) of a family with autosomal dominant myopathy were examined in detail: the patients presented the same picture of skeletal muscle damage associated with cardiac damage; genetic analysis revealed a nonsense variant c.70051C>Tp.(Arg23351) in the TTN gene; RNA sequencing showed reduced expression of the mutated allele and Western … [Read more]
Danon disease: a single-centre Chinese retrospective study of 29 paediatric cases
Between July 2014 and December 2023, 21 boys and 8 girls undergoing follow-up at a paediatric cardiology centre in Shanghai were genetically diagnosed with Danon disease, at around 7 years of age for the boys and slightly later (9.4 years on average) for the girls. Nearly half had a family history of this very rare … [Read more]
